Table 1.
Participant characteristics. (A) participants with lower limb amputation (LLA) and (B) control participants. The final row of each table shows the group means (SD).
| (A) Participants with LLA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sex (M/F) | Age | Body mass | Amp. levela | Amp. etiology | ABC Score (%) | PLUS-M score (Adjusted %) | AMP PRO score/K-level | |||
| M | 64 | 108.9 | TF | Trauma | 87.50 | 79.90 | 43/K4 | |||
| M | 41 | 104.3 | TF | Cancer | 93.75 | 57.80 | 44/K4 | |||
| M | 76 | 90.7 | TF | Trauma | 73.75 | 70.20 | 41/K3 | |||
| M | 59 | 95.3 | TF | Trauma | 87.20 | 57.80 | 45/K4 | |||
| M | 49 | 59.0 | TT | Dysvasc. | 85.00 | 67.00 | 46/K4 | |||
| M | 60 | 99.8 | TT | Dysvasc. | 93.10 | 79.90 | 43/K4 | |||
| F | 63 | 58.1 | TT | Cancer | 97.50 | 89.90 | 46/K4 | |||
| F | 71 | 90.7 | TT | Trauma | 80.60 | 57.80 | 43/K4 | |||
| 6M/2F | 60.4 (±11.2) | 88.4 (±19.4) | 4TF/4TT | N/A | 87.30 (±7.68) | 69.99 (±12.1) | 43.89/K4 (±1.73) | |||
| (B) Control participants | ||||||||||
|
(Sex (M/F) |
Age |
Body mass |
ABC Score (%) |
|||||||
| M | 60 | 80.0 | 88.75 | |||||||
| M | 41 | 72.6 | 99.40 | |||||||
| M | 61 | 94.3 | 97.50 | |||||||
| M | 48 | 65.0 | 100.00 | |||||||
| M | 61 | 83.9 | 96.60 | |||||||
| M | 68 | 64.9 | 98.10 | |||||||
| F | 58 | 43.1 | 98.75 | |||||||
| F | 54 | 63.0 | 98.75 | |||||||
| 6 M/2F | 56.4 (±8.50) | 70.9 (±15.6) | 97.23 (±3.59) | |||||||
ABC: Activity-specific Balance Confidence Scale; PLUS-M: Prosthetic Limb User’s Survey of Mobility; AMP PRO: Amputee Mobility Predictor with prosthetics.
aAmp (amputation) level: TF = transfemoral amputation, defined as at or above knee; TT = transtibial amputation, defined as below knee.